Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium

BACKGROUND: Support for early detection of lung cancer has emerged from the National Lung Screening Trial (NLST), in which low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20 % relative to chest x-ray. The US Preventive Services Task Force (USPSTF) recently recommended...

Descripción completa

Detalles Bibliográficos
Autores principales: Birse, Charles E., Lagier, Robert J., FitzHugh, William, Pass, Harvey I., Rom, William N., Edell, Eric S., Bungum, Aaron O., Maldonado, Fabien, Jett, James R., Mesri, Mehdi, Sult, Erin, Joseloff, Elizabeth, Li, Aiqun, Heidbrink, Jenny, Dhariwal, Gulshan, Danis, Chad, Tomic, Jennifer L., Bruce, Robert J., Moore, Paul A., He, Tao, Lewis, Marcia E., Ruben, Steve M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537594/
https://www.ncbi.nlm.nih.gov/pubmed/26279647
http://dx.doi.org/10.1186/s12014-015-9090-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537594/
https://www.ncbi.nlm.nih.gov/pubmed/26279647
http://dx.doi.org/10.1186/s12014-015-9090-9

Ejemplares similares